信隆健康: 半年报董事会决议公告

Group 1 - The board of directors of Shenzhen Xinlong Health Industry Development Co., Ltd. held its 14th meeting of the 7th session on August 21, 2025, with 8 out of 11 directors present [1] - The board unanimously approved the 2025 semi-annual report and its summary, confirming compliance with legal and regulatory requirements [1][2] - The semi-annual report will be published on August 23, 2025, on the designated information disclosure media [2] Group 2 - The board approved a proposal to repurchase and cancel 75,000 unvested restricted stocks at an adjusted price of 3.49 yuan per share, which will be submitted for review at the first extraordinary general meeting of 2025 [2][3] - The decision to cancel the restricted stocks was made due to unmet performance targets for the first vesting period of the 2023 restricted stock incentive plan [3] Group 3 - The board unanimously passed a resolution to reduce the registered capital from 368,060,000 yuan to 366,241,950 yuan, and to cancel the supervisory board [4][5] - The company will amend its articles of association accordingly, transferring the supervisory responsibilities to the audit committee of the board [4] Group 4 - The board proposed several amendments to internal governance documents, including the rules for shareholder meetings, board meetings, independent director systems, and audit committee rules, all of which require shareholder approval [5][6][7][8] - The board also nominated candidates for the 8th board of directors, including 6 non-independent directors and 4 independent directors, to be elected at the upcoming shareholder meeting [9][10]